Tradestie Institutional Equity Comparison Engine

CRMD vs ALDX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRMD Overall Edge

CRMD Captures Institutional Edge (3โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, CRMD trades at 49.0x Forward P/E with 41.0% operating margin (-47.7% YoY revenue) versus ALDX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro) against ALDX sits in BREAKDOWN (29th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
CRMD 49.0x vs ALDX N/M Fwd P/E
Growth & Margin Winner CRMD
Op Margin 41.0% vs 0.0% ยท YoY -47.7% vs +0.0%
Momentum & Technical Winner CRMD
1Y -56.2% vs -86.7% ยท 52W Pos 3% vs 3%
Options & Structure Winner Tie
BREAKDOWN (25th %ile IV) vs BREAKDOWN (29th %ile IV)
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0
ALDX NASDAQ
Aldeyra Therapeutics, Inc.
Pharmaceutical Preparations
$0.67
+4.02% 1D
Market Cap $38.2M
1M Return -4.34%
1Y Return -86.66%
Forward P/E N/M
Unified AI Score
41.6 / 100 SELL
Tech 40.0 Fund 55.0 Flow 69.0 Mom 58.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRMD -56.16% ALDX -86.66% Spread: +30.5 pp (CRMD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CRMD TTM Op. Margin: 41.0% ALDX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CRMD vs ALDX. Trailing 12-month operating profitability (CRMD 41.0% vs ALDX 0.0%) and valuation multiples (CRMD 49.0x vs ALDX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRMD (8) vs ALDX (2)
Institutional Metric CRMD ALDX Criterion Row Winner
Market Capitalization Scale $384.7M $38.2M Larger Scale CRMD
Trailing P/E Ratio Valuation 2.4x N/M Lower Multiple CRMD
Forward P/E Ratio Valuation 49.0x N/M Lower Multiple CRMD
Revenue Growth (YoY) Growth -47.7% +0.0% Higher Growth ALDX
Operating Margin (TTM) Profitability 41.0% 0.0% Higher Margin CRMD
Net Profit Margin Profitability 15.5% 0.0% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency 15.3% -45.3% Higher ROE CRMD
52-Week Range Position Momentum 3% ($5โ€“$13) 3% ($1โ€“$6) Stronger Trend CRMD
Beta / 30D Volatility Risk Regime 1.20ฮฒ ยท 107% Vol 1.12ฮฒ ยท 89% Vol Lower Realized Risk ALDX
Unified Institutional Score Composite Signal 53.2 / 100 (HOLD) 41.6 / 100 (SELL) Higher Composite CRMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRMD vs ALDX Buy Guide
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ALDX BREAKDOWN
165d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 29th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ALDX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRMD nor ALDX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.